It doesn't matter. The point is that they have approved 2 billion more shares and continue to issue toxic debt. Any sales they generate will not be enough to negate the constant dilution. $5.8m in notes net of the discounts and looks like they will need to raise more debt to just keep the lights on.
Yes. They are real people with healthcare industry experience.
Company was registered in California in May of this year. Robert Crousore is the President. The owner info is protected by LegalZoom. Don't know if Robert is the owner or working for the anonymous owner.
If, for the sake of argument, Sofpulse is Magniant's first product to market, may not be such a bad thing. We will have 100% of their attention. They will be eager to get the business rolling.
Market Data 
Markets 
AI
